Bayard R. Huck

1.3k total citations
28 papers, 995 citations indexed

About

Bayard R. Huck is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Bayard R. Huck has authored 28 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Bayard R. Huck's work include Chemical Synthesis and Analysis (10 papers), Click Chemistry and Applications (6 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Bayard R. Huck is often cited by papers focused on Chemical Synthesis and Analysis (10 papers), Click Chemistry and Applications (6 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Bayard R. Huck collaborates with scholars based in United States, Germany and Italy. Bayard R. Huck's co-authors include Samuel H. Gellman, Lisa Kötzner, Klaus Urbahns, John D. Fisk, Rienk Offringa, Ulrich Arnold, Ronald T. Raines, Douglas R. Powell, Laurie A. Christianson and Heather E. Stanger and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Reviews Drug Discovery.

In The Last Decade

Bayard R. Huck

28 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bayard R. Huck United States 16 737 379 177 120 108 28 995
Alessandro Zorzi Switzerland 8 825 1.1× 278 0.7× 158 0.9× 54 0.5× 130 1.2× 12 1.1k
Adrian Glas Germany 9 833 1.1× 349 0.9× 163 0.9× 26 0.2× 78 0.7× 10 954
Fayna García‐Martin Japan 17 692 0.9× 370 1.0× 94 0.5× 189 1.6× 47 0.4× 28 864
Kareem A. H. Chehade United States 11 771 1.0× 338 0.9× 351 2.0× 80 0.7× 22 0.2× 13 1.2k
Michael S. Bernatowicz United States 17 906 1.2× 518 1.4× 134 0.8× 53 0.4× 58 0.5× 35 1.4k
Timothy W. Craven United States 16 711 1.0× 292 0.8× 105 0.6× 44 0.4× 74 0.7× 21 832
Jessica Iegre United Kingdom 14 533 0.7× 180 0.5× 167 0.9× 31 0.3× 38 0.4× 19 707
Yujia Wang China 11 619 0.8× 413 1.1× 91 0.5× 35 0.3× 54 0.5× 14 827
Martin Quibell United Kingdom 21 1.2k 1.6× 653 1.7× 204 1.2× 25 0.2× 115 1.1× 42 1.4k
Stefano Tomassi Italy 16 497 0.7× 156 0.4× 147 0.8× 73 0.6× 30 0.3× 42 746

Countries citing papers authored by Bayard R. Huck

Since Specialization
Citations

This map shows the geographic impact of Bayard R. Huck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bayard R. Huck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bayard R. Huck more than expected).

Fields of papers citing papers by Bayard R. Huck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bayard R. Huck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bayard R. Huck. The network helps show where Bayard R. Huck may publish in the future.

Co-authorship network of co-authors of Bayard R. Huck

This figure shows the co-authorship network connecting the top 25 collaborators of Bayard R. Huck. A scholar is included among the top collaborators of Bayard R. Huck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bayard R. Huck. Bayard R. Huck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schiemann, Kai, Kalyan C. Nallaparaju, Carsten Boesler, et al.. (2024). Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo. Molecular Cancer Therapeutics. 23(11). 1517–1529. 6 indexed citations
2.
Hartung, Ingo V., Bayard R. Huck, & Alejandro Crespo. (2023). Rules were made to be broken. Nature Reviews Chemistry. 7(1). 3–4. 45 indexed citations
3.
Guler, Satenig, Alejandro Crespo, Richard D. Caldwell, et al.. (2023). Selective Wee1 Inhibitors Led to Antitumor Activity In Vitro and Correlated with Myelosuppression. ACS Medicinal Chemistry Letters. 14(5). 566–576. 14 indexed citations
4.
Offringa, Rienk, Lisa Kötzner, Bayard R. Huck, & Klaus Urbahns. (2022). The expanding role for small molecules in immuno-oncology. Nature Reviews Drug Discovery. 21(11). 821–840. 92 indexed citations
5.
Kötzner, Lisa, Bayard R. Huck, Sakshi Garg, & Klaus Urbahns. (2020). Small molecules—Giant leaps for immuno-oncology. Progress in medicinal chemistry. 59. 1–62. 3 indexed citations
6.
Huck, Bayard R., Lisa Kötzner, & Klaus Urbahns. (2017). Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies. Angewandte Chemie International Edition. 57(16). 4412–4428. 111 indexed citations
7.
Huck, Bayard R. & Igor Mochalkin. (2017). Recent progress towards clinically relevant ATP-competitive Akt inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(13). 2838–2848. 29 indexed citations
8.
Tsimberidou, Apostolia M., Claire F. Verschraegen, Gregory M. Heestand, et al.. (2015). A first in human, dose escalation trial of MSC2363318A – a dual p70S6K/Akt inhibitor, for patients with advanced malignancies. Annals of Oncology. 26. ii25–ii25. 5 indexed citations
9.
Huck, Bayard R., Hui Tian, Jing‐Jer Lin, et al.. (2014). Abstract 4516: Evaluation of p70S6K/Akt inhibitor MSC2363318A in patient derived xenograft (PDX) models of breast cancer. Cancer Research. 74(19_Supplement). 4516–4516. 1 indexed citations
10.
Karra, Srinivasa, Yufang Xiao, Xiaoling Chen, et al.. (2013). SAR and evaluation of novel 5H-benzo[c][1,8]naphthyridin-6-one analogs as Aurora kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(10). 3081–3087. 15 indexed citations
11.
Arnold, Ulrich, Bayard R. Huck, Samuel H. Gellman, & Ronald T. Raines. (2012). Protein prosthesis: β‐peptides as reverse‐turn surrogates. Protein Science. 22(3). 274–279. 18 indexed citations
12.
Huck, Bayard R., Luis Llamas, Jianping Song, et al.. (2006). The identification of pyrimidine-diazabicyclo[3.3.0]octane derivatives as 5-HT2C receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16(11). 2891–2894. 12 indexed citations
13.
Huck, Bayard R., Luis Llamas, Jianping Song, et al.. (2006). The design and synthesis of a tricyclic single-nitrogen scaffold that serves as a 5-HT2C receptor agonist. Bioorganic & Medicinal Chemistry Letters. 16(15). 4130–4134. 22 indexed citations
14.
Huck, Bayard R. & Samuel H. Gellman. (2005). Synthesis of 2,2-Disubstituted Pyrrolidine-4-carboxylic Acid Derivatives and Their Incorporation into β-Peptide Oligomers. The Journal of Organic Chemistry. 70(9). 3353–3362. 28 indexed citations
15.
Tumey, L. Nathan, David Bom, Bayard R. Huck, et al.. (2004). The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(2). 277–281. 70 indexed citations
16.
Tumey, L. Nathan, Bayard R. Huck, Jianmin Wang, et al.. (2004). The identification and optimization of 2,4-diketobutyric acids as flap endonuclease 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(19). 4915–4918. 17 indexed citations
17.
Arnold, Ulrich, et al.. (2002). Protein Prosthesis:  A Semisynthetic Enzyme with a β-Peptide Reverse Turn. Journal of the American Chemical Society. 124(29). 8522–8523. 105 indexed citations
18.
Lai, Jonathan R., Bayard R. Huck, Bernard Weisblum, & Samuel H. Gellman. (2002). Design of Non-Cysteine-Containing Antimicrobial β-Hairpins:  Structure−Activity Relationship Studies with Linear Protegrin-1 Analogues. Biochemistry. 41(42). 12835–12842. 71 indexed citations
19.
Huck, Bayard R., John D. Fisk, & Samuel H. Gellman. (2000). Promotion of Sheet Formation in α-Peptide Strands by a β-Peptide Reverse Turn. Organic Letters. 2(17). 2607–2610. 60 indexed citations
20.
Huck, Bayard R., Joseph M. Langenhan, & Samuel H. Gellman. (1999). Non-Hydrogen-Bonded Secondary Structure in β-Peptides:  Evidence from Circular Dichroism of (S)-Pyrrolidine-3- carboxylic Acid Oligomers and (S)-Nipecotic Acid Oligomers. Organic Letters. 1(11). 1717–1720. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandro Zorzi Breakdown of academic impact, for papers by Adrian Glas Breakdown of academic impact, for papers by Fayna García‐Martin Breakdown of academic impact, for papers by Kareem A. H. Chehade Breakdown of academic impact, for papers by Michael S. Bernatowicz Breakdown of academic impact, for papers by Timothy W. Craven Breakdown of academic impact, for papers by Jessica Iegre Breakdown of academic impact, for papers by Yujia Wang Breakdown of academic impact, for papers by Martin Quibell Breakdown of academic impact, for papers by Stefano Tomassi
Rankless by CCL
2026